Live Webinar:
Effect of Rivaroxaban and Aspirin on Patients with PAD Undergoing Revascularisation
Tuesday, October 8, 2024
Start Time: 4:00 PM GMT | 6:00 PM CEST | 12:00 PM ET | 11:00 AM CT | 10:00 AM MT | 9:00 AM MT | 9:00 AM PT
Duration: 1-hour
In this webinar, leading experts will explore the impact of Rivaroxaban and Aspirin on PAD patients, drawing on key findings from the COMPASS and VOYAGER trials.
Faculty: Prof. Marianne Brodmann, MD (Medical University of Graz, Austria), Prof. Dr. med. Rupert Bauersachs (CCB Gefäß Centrum), Dr. Marc Bonaca (University of Colorado School of Medicine)
Why You Should Attend
- Discover new evidence-based approaches to managing PAD.
- Learn how trial outcomes can inform and optimize clinical practice.
- Engage with experts in the field of vascular health.
Who Should Attend? Vascular specialists, interventional cardiologists, surgeons, and other healthcare professionals involved in PAD treatment.
Webinar Program
18:00 – 18:05: Welcome and Overview
Prof. Marianne Brodmann, MD
18:05 – 18:20: Rationale for COMPASS and VOYAGER Trials
Prof. Dr. med. Rupert Bauersachs
18:20 – 18:35: VOYAGER in Endovascular and Surgical Contexts
Prof. Marianne Brodmann, MD
18:35 – 18:50: Substudy Outcomes: Impact on Clinical Practice
Dr. Marc Bonaca
18:50 – 19:00: Wrap-Up
Prof. Marianne Brodmann, MD